Literature DB >> 4294443

Mefenamic acid in rheumatoid arthritis.

A B Myles, P A Bacon, K A Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4294443      PMCID: PMC1010434          DOI: 10.1136/ard.26.6.494

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  TRIAL OF MEFENAMIC ACID.

Authors:  W J CAHILL; R D HILL; J JESSOP; P H KENDALL
Journal:  Ann Phys Med       Date:  1965-02

2.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

3.  Indomethacin in in-patient treatment of rheumatoid arthritis.

Authors:  D A Pitkeathly; N R Banerjee; R Harris; J Sharp
Journal:  Ann Rheum Dis       Date:  1966-07       Impact factor: 19.103

4.  Indomethacin in rheumatoid arthritis. A comparative objective evaluation with adrenocorticosteroids.

Authors:  C J Smyth
Journal:  Arthritis Rheum       Date:  1965-10

5.  Indomethacin and phenylbutazone: a comparison.

Authors:  F D Hart; P L Boardman
Journal:  Br Med J       Date:  1965-11-27

6.  Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis.

Authors:  D E Barnardo; H L Currey; R M Mason; W R Fox; M Weatherall
Journal:  Br Med J       Date:  1966-08-06

7.  Anti-inflammatory, antipyretic and antinociceptive properties of N-(2,3-xylyl)anthranilic acid (mefenamic acid).

Authors:  C V WINDER; J WAX; L SCOTTI; R A SCHERRER; E M JONES; F W SHORT
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

  7 in total
  6 in total

Review 1.  Rheumatoid arthritis. Surgical treatment.

Authors:  G P Arden; S H Harrison; B M Ansell
Journal:  Br Med J       Date:  1970-12-05

2.  Gastric ulcer and the anti-arthritic drugs.

Authors:  J H Emmanuel; R D Montgomery
Journal:  Postgrad Med J       Date:  1971-04       Impact factor: 2.401

3.  Mefenamic acid decreases inflammation but not joint lesions in experimental osteoarthritis.

Authors:  Grazielle C Aguiar; Celso M Queiroz-Junior; Giovana L Sitta; Flávio A Amaral; Mauro M Teixeira; Marcelo V Caliari; Anderson J Ferreira
Journal:  Int J Exp Pathol       Date:  2016-12       Impact factor: 1.925

4.  Oral antipyretic therapy: evaluation of the N-aryl-anthranilic acid derivatives mefenamic acid, tolfenamic acid and flufenamic acid.

Authors:  S Keinänen; S Similä; K Kouvalainen
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

5.  Autoimmune haemolytic anaemia and mefenamic acid therapy.

Authors:  G L Scott; A B Myles; P A Bacon
Journal:  Br Med J       Date:  1968-08-31

6.  A phenome-guided drug repositioning through a latent variable model.

Authors:  Halil Bisgin; Zhichao Liu; Hong Fang; Reagan Kelly; Xiaowei Xu; Weida Tong
Journal:  BMC Bioinformatics       Date:  2014-08-08       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.